Clinical Evidence: A New Standard in AFib Treatment

AI-Guided Treatment That’s Changing Lives

Persistent atrial fibrillation (AFib) can disrupt daily life, limit activity, and cause constant worry about what’s next. For many, standard treatments haven’t provided lasting relief. But now, a new approach is delivering powerful results. Backed by strong clinical evidence, AI-guided ablation is helping more patients experience lasting freedom from AFib. 

The TAILORED-AF Clinical Trial

The TAILORED-AF trial was a large, international clinical study designed to compare traditional ablation with a new, AI-guided approach. This study included: 

  • 374 patients with persistent or long-standing persistent AFib 
  • 12-month follow-up to track long-term success 
  • A randomized controlled design, the gold standard for clinical research 

The Results Speak for Themselves

Patients who received AI-guided ablation experienced significantly better outcomes: 

  • 88% were free from AFib at 12 months after just one procedure, compared to just 70% in the group that received standard ablation care 

And for women, the results were even more powerful: 

  • 76% of women treated with AI-guided ablation were free from AFib at 12 months, compared to just 50% in the standard care group 

Expert Guidance

Connect with local AFib specialists who are ready to help.

You don’t have to face AFib alone. Our Provider Finder makes it easy to locate professionals who are experienced with our technology—so you can feel confident you’re getting the care you deserve.

Find a Provider
  1. Deisenhofer, I., Albenque, JP., Busch, S. et al. Artificial intelligence for individualized treatment of persistent atrial fibrillation: a randomized controlled trial. Nat Med 31, 1286–1293 (2025). https://doi.org/10.1038/s41591-025-03517-w